New Biological Drug Development

UGA Biopharma offers all services along the life-cycle of biosimilar development culminating in the delivery of a ready-to-use research cell bank (RCB) or GMP master cell bank (MCB).

Cell Line Development for new biopharmaceutical drug candidates           

UGA offers a High Speed Cell Line Development Services. Get your highly productive, stable and safe cell line expressing your new biopharmaceutical drug candidate in a very short development time.


Biosimilar Development           

UGA Biopharma provides Customised Biosimilar Development Services in very short development time. Within 7 months UGA Biopharm can perform:

  • Cell line development
  • Upstream development
  • Downstream development
  • Analytics

  • You can find further information on our homepage at:
    Biosimilar Development

    Customized Media Development           

    Depending on your requirements UGA Biopharma can improve during a Customised Media and Feed Development service:

  • Cell growth and viability
  • Productivity
  • Quality attributes
  • Solubility

  • Contact us!

    UGA Biopharma GmbH
    16761 Hennigsdorf, Neuendorfstraße 20a (Germany)
    E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
    Phone: +49 (0)3302 / 2024900